Annexon
Most recent annual filing: 2026-03-15
- ANX1502 C1 readout2026ANX1502 C1 readout, 2026, notable
- ANX1502 POC readout2H 2026ANX1502 POC readout, 2H 2026, notable
- Vonaprument Ph3 topline4Q 2026Vonaprument Ph3 topline, 4Q 2026, thesis-defining
- Tanruprubart BLA filing4Q 2026Tanruprubart BLA filing, 4Q 2026, material
- loan covenant trial startMar 31, 2027loan covenant trial start, Mar 31, 2027, routine
- loan tranche corporate updateSep 30, 2027loan tranche corporate update, Sep 30, 2027, notable
Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.
Pipeline (6 active programs)
Biotech Distilled coverage (6)
- 2026-08-13 UPDATE: Annexon (ANNX) - The Binary Just Grew a Second Half 🔒 Paid
- 2026-08-07 UPDATE: Annexon (ANNX) - The Silent Killer Gets Its First Western Data 🔒 Paid
- 2026-07-30 UPDATE: Annexon (ANNX) - The Dilution Gun Gets a Debt Silencer 🔒 Paid
- 2026-05-08 UPDATE: Annexon (ANNX) - The Dilution Gun Has Fired 🔒 Paid
- 2026-04-04 UPDATE: Annexon (ANNX) - Spring Cleaning, Shelf Registrations, and the Dilution Gap 🔒 Paid
- 2026-02-27 Annexon (ANNX): Scientific Deep Dive for ANX007 and Pipeline Products 🔒 Paid
Articles open on Substack. Some deep dives are subscriber-only.